Arnold & Porter LLP
Treatment of complement-associated disorders
The present invention concerns a recently discovered macrophage specific receptor, CRIg, and its use in the prevention and treatment of complement-associated disorders, including complement-associated eye conditions, such as age-related macular degeneration (AMD) and choroidal neovascularization (CNV).
Genentech, Inc.
A C A A A A G A A A C A A A C A A G A A A A A C A A A A A A A A A
A61K C07K A61P A61P A61P A61P G01N A61P A61P A61P C07K A61P A61P A61P C07K A61P A61P G01N A61P A61P A61P A61P A61P C07K A61P A61P A61P A61P A61P A61P A61P A61P A61P
additional additional inventional inventional inventional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Karim Yussef Sherman Avi Menno Austin L. Kenneth James William I. Audrey
Helmy Fong Ashkenazi Van Lookeren Gurney Katschke, Jr. Wood Goddard